194 related articles for article (PubMed ID: 26108302)
1. Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma.
Wang CC; Kao JH
Hepatol Int; 2015 Oct; 9(4):514-9. PubMed ID: 26108302
[TBL] [Abstract][Full Text] [Related]
2. [Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma adjacent to the diaphragm].
Adán Merino L; Olveira Martín A; Pérez Robledo JP; Prieto I; Gea Rodriguez F; Castillo Grau P; Martín Arranz E; Alonso Gamarra E; Mora Sanz P
Gastroenterol Hepatol; 2010 Dec; 33(10):709-15. PubMed ID: 21059478
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience.
Rhim H; Lim HK; Kim YS; Choi D
AJR Am J Roentgenol; 2008 Jan; 190(1):91-8. PubMed ID: 18094298
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients.
Song I; Rhim H; Lim HK; Kim YS; Choi D
Eur Radiol; 2009 Nov; 19(11):2630-40. PubMed ID: 19557416
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
[TBL] [Abstract][Full Text] [Related]
6. [Long term (5 years) outcome of radiofrequency ablation for hepatocellular carcinoma in 256 cases].
Chen MH; Yan K; Yang W; Gao W; Dai Y; Huo L; Zhang H; Huang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):671-2. PubMed ID: 16378128
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of radiofrequency ablation with artificial ascites for hepatocellular carcinoma.
Nishimura M; Nouso K; Kariyama K; Wakuta A; Kishida M; Wada N; Higashi T; Yamamoto K
Acta Med Okayama; 2012; 66(3):279-84. PubMed ID: 22729109
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation of problematically located hepatocellular carcinoma: tailored approach.
Chen MH; Yang W; Yan K; Hou YB; Dai Y; Gao W; Zhang H; Wu W
Abdom Imaging; 2008; 33(4):428-36. PubMed ID: 17639375
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy.
Kang TW; Rhim H; Lee MW; Kim YS; Choi D; Lee WJ; Lim HK
AJR Am J Roentgenol; 2011 Apr; 196(4):907-13. PubMed ID: 21427344
[TBL] [Abstract][Full Text] [Related]
10. Benefits of artificially induced pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma located on the liver surface and in the hepatic dome.
Iwai S; Sakaguchi H; Fujii H; Kobayashi S; Morikawa H; Enomoto M; Tamori A; Kawada N
Hepatogastroenterology; 2012; 59(114):546-50. PubMed ID: 22353522
[TBL] [Abstract][Full Text] [Related]
11. First-line radiofrequency ablation with or without artificial ascites for hepatocellular carcinomas in a subcapsular location: local control rate and risk of peritoneal seeding at long-term follow-up.
Kang TW; Lim HK; Lee MW; Kim YS; Choi D; Rhim H
Clin Radiol; 2013 Dec; 68(12):e641-51. PubMed ID: 23973161
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites.
Uehara T; Hirooka M; Ishida K; Hiraoka A; Kumagi T; Kisaka Y; Hiasa Y; Onji M
J Gastroenterol; 2007 Apr; 42(4):306-11. PubMed ID: 17464460
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation for hepatic tumors abutting the diaphragm: clinical assessment of the heat-sink effect of artificial ascites.
Nam SY; Rhim H; Kang TW; Lee MW; Kim YS; Choi D; Lee WJ; Park Y; Chang I; Lim HK
AJR Am J Roentgenol; 2010 Feb; 194(2):W227-31. PubMed ID: 20093579
[TBL] [Abstract][Full Text] [Related]
14. Value of artificial ascites to assist thermal ablation of liver cancer adjacent to the gastrointestinal tract in patients with previous abdominal surgery.
Huang Q; Li J; Zeng Q; Tan L; Zheng R; He X; Li K
BMC Cancer; 2020 Aug; 20(1):763. PubMed ID: 32795279
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of radiofrequency ablation of 343 patients with hepatic tumor and the relevant complications].
Chen MH; Yan K; Yang W; Gao W; Dai Y; Wang YB; Zhang H; Huo L; Xing BC; Huang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):292-6. PubMed ID: 15968323
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites.
Rhim H; Lim HK
Abdom Imaging; 2009; 34(3):371-80. PubMed ID: 18463915
[TBL] [Abstract][Full Text] [Related]
17. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of intraperitoneal saline infusion for percutaneous radiofrequency ablation for hepatocellular carcinoma.
Park SY; Tak WY; Jeon SW; Cho CM; Kweon YO; Kim SK; Choi YH
Eur J Radiol; 2010 Jun; 74(3):536-40. PubMed ID: 19398290
[TBL] [Abstract][Full Text] [Related]
19. Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract.
Kondo Y; Yoshida H; Shiina S; Tateishi R; Teratani T; Omata M
Br J Surg; 2006 Oct; 93(10):1277-82. PubMed ID: 16783759
[TBL] [Abstract][Full Text] [Related]
20. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma.
Cheung TT; Ng KK; Poon RT; Fan ST
J Hepatobiliary Pancreat Surg; 2009; 16(5):655-60. PubMed ID: 19370304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
